NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
25.59
+0.67 (2.69%)
Sep 2, 2026, 4:00 PM EDT - Market closed
NAMS Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Maintains $48 | Buy | Maintains | $48 | +87.57% | Aug 7, 2026 |
| Truist Financial | Truist Financial | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 6, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $50 | Buy | Reiterates | $50 | +95.39% | Aug 6, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $58 | Buy | Reiterates | $58 | +126.65% | Aug 6, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 6, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $51 → $50 | Buy | Maintains | $51 → $50 | +95.39% | Aug 6, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $55 | Buy | Maintains | $55 | +114.93% | Aug 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 | Buy | Reiterates | $52 | +103.20% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.